MAP2K7 and cancer: Results from in vitro studies show that AP effectively inhibits cancer cell growth and leads to the death of cancer cells in a dose- and time-dependent manner, via apoptosis and autophagy through the inhibition of the PI3K/Akt/mTOR and RAF/MEK/ERK pathways [22,23,26,27].